Adding docetaxel and/or zoledronic acid for hormone-‐naïve prostate cancer (STAMPEDE) : survival results from an adaptive multi-‐arm multi-‐stage platform randomised controlled trial
2015
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI